Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
Johnson & Johnson (JNJ) is trading at $243.04 as of April 2, 2026, posting a 0.44% decline in the current session. This analysis covers key technical levels, sector context, and potential price scenarios for the diversified healthcare conglomerate, which operates across pharmaceutical, medical technology, and consumer health segments. No recent earnings data is available for JNJ at the time of writing, so recent price action has been driven largely by broader market sentiment and sector trends r
Why is Johnson & (JNJ) Stock underperforming the market | Price at $243.04, Down 0.44% - Trending Stock Ideas
JNJ - Stock Analysis
3930 Comments
1802 Likes
1
Waldemar
Active Contributor
2 hours ago
This feels like step 9 of confusion.
👍 21
Reply
2
Datavia
Influential Reader
5 hours ago
I feel like I was just a bit too slow.
👍 283
Reply
3
Alexz
Elite Member
1 day ago
Indices are testing key technical levels, and a breakout could determine the next directional move.
👍 117
Reply
4
Lafawn
Legendary User
1 day ago
Markets are showing short-term consolidation before the next move.
👍 213
Reply
5
Cesilee
Active Reader
2 days ago
Timing really wasn’t on my side.
👍 99
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.